pioglitazone has been researched along with Nephrolithiasis in 1 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Nephrolithiasis: Formation of stones in the KIDNEY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Niu, SW | 1 |
| He, JS | 1 |
| You-Hsien Lin, H | 1 |
1 other study available for pioglitazone and Nephrolithiasis
| Article | Year |
|---|---|
Pioglitazone and nephrolithiasis.
Topics: Humans; Kidney Calculi; Nephrolithiasis; Pioglitazone; Uric Acid | 2019 |